← Every applicant
Accord Hlthcare FDA Approvals
32 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| LENALIDOMIDENew drugNov 14, 2025CAPSULE, ORAL |
| CLOMIPHENE CITRATENew drugOct 3, 2025TABLET, ORAL |
| DEHYDRATED ALCOHOLNew drugJun 23, 2025SOLUTION, INTRA-ARTERIAL |
| PROGESTERONENew drugNov 21, 2023INJECTABLE, INJECTION |
| FESOTERODINE FUMARATENew drugJan 4, 2023TABLET, EXTENDED RELEASE, ORAL |
| CARMUSTINENew drugDec 27, 2022INJECTABLE, INJECTION |
| BENDAMUSTINE HYDROCHLORIDENew drugDec 7, 2022POWDER, INTRAVENOUS |
| CABAZITAXELNew drugOct 26, 2022SOLUTION, INTRAVENOUS |
| NALOXONE HYDROCHLORIDENew drugOct 26, 2022INJECTABLE, INJECTION |
| METOPROLOL SUCCINATENew drugOct 18, 2022TABLET, EXTENDED RELEASE, ORAL |
| CLOBAZAMNew drugSep 6, 2022SUSPENSION, ORAL |
| BORTEZOMIBNew drugJul 26, 2022INJECTABLE, INTRAVENOUS, SUBCUTANEOUS |
| BORTEZOMIBNew drugJul 26, 2022SOLUTION, INTRAVENOUS |
| OSELTAMIVIR PHOSPHATENew drugJul 25, 2022CAPSULE, ORAL |
| PEMETREXED DISODIUMNew drugJul 19, 2022SOLUTION, INTRAVENOUS |
| LACOSAMIDENew drugJul 12, 2022TABLET, ORAL |
| PEMETREXED DISODIUMNew drugMay 25, 2022POWDER, INTRAVENOUS |
| CARMUSTINENew drugMay 16, 2022POWDER, INTRAVENOUS |
| REGADENOSONNew drugApr 11, 2022SOLUTION, INTRAVENOUS |
| PIRFENIDONENew drugJan 25, 2022TABLET, ORAL |
| PIRFENIDONENew drugJan 20, 2022CAPSULE, ORAL |
| SOLIFENACIN SUCCINATENew drugJan 4, 2022TABLET, ORAL |
| CABAZITAXELNew drugDec 29, 2021SOLUTION, INTRAVENOUS |
| DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATENew drugNov 22, 2021TABLET, ORAL |
| FLUOROURACILNew drugOct 7, 2021CREAM, TOPICAL |
| TRIENTINE HYDROCHLORIDENew drugAug 30, 2021CAPSULE, ORAL |
| ATROPINE SULFATENew drugJul 26, 2021SOLUTION, INTRAVENOUS |
| ARGATROBAN IN SODIUM CHLORIDENew drugJun 7, 2021SOLUTION, INTRAVENOUS |
| RANOLAZINENew drugMay 18, 2021TABLET, EXTENDED RELEASE, ORAL |
| VILAZODONE HYDROCHLORIDENew drugApr 27, 2021TABLET, ORAL |
| ATROPINE SULFATENew drugMar 19, 2021SOLUTION, INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL |
| PALONOSETRON HYDROCHLORIDENew drugMar 15, 2021INJECTABLE, INTRAVENOUS |